{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T14:28:46Z","timestamp":1778509726405,"version":"3.51.4"},"reference-count":131,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Since their introduction to clinical medicine in 1989, botulinum toxin injections have been used for many indications. First used for nonsurgical management of strabismus, botulinum toxin injections are now widely used in plastic and reconstructive surgery for aesthetic indications; however, nonaesthetic indications of botulinum toxin have grown tremendously over the past two decades and span numerous specialties, including urology, dermatology, ophthalmology, otolaryngology, gynecology, plastic surgery, general surgery, and neurology. The present review aims to highlight nonaesthetic indications of botulinum toxin that are most relevant to the plastic surgeon with an emphasis on evidence-based practice.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A PubMed search with manual reference checking was conducted to find the most relevant and influential articles on the nonaesthetic uses of botulinum toxin within the realm of adult plastic surgery. Studies were then categorized into areas of use, and quality of evidence for each category was highlighted.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Botulinum toxin has numerous nonaesthetic indications in plastic surgery, including for select pain-related disorders, skeletal muscle activity disorders, exocrine gland hyperfunction, wound healing, Raynaud phenomenon, abdominal wall reconstruction, and prosthetic breast reconstruction and augmentation. Although these indications have been widely reported, high-quality evidence supporting efficacy, optimal dose, and injection protocol with randomized controlled trials is lacking in many areas.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Botulinum toxin is widely used in plastic surgery for a variety of nonaesthetic indications. Future studies should focus on investigating efficacy and best practice with high level of evidence research.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/prs.0000000000006908","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T17:34:42Z","timestamp":1592933682000},"page":"157-170","source":"Crossref","is-referenced-by-count":18,"title":["Nonaesthetic Applications for Botulinum Toxin in Plastic Surgery"],"prefix":"10.1097","volume":"146","author":[{"given":"Matthew D.","family":"Freeman","sequence":"first","affiliation":[{"name":"From the Division of Plastic and Reconstructive Surgery, Department of Surgery, Mount Sinai Hospital."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilana G.","family":"Margulies","sequence":"additional","affiliation":[{"name":"From the Division of Plastic and Reconstructive Surgery, Department of Surgery, Mount Sinai Hospital."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paymon","family":"Sanati-Mehrizy","sequence":"additional","affiliation":[{"name":"From the Division of Plastic and Reconstructive Surgery, Department of Surgery, Mount Sinai Hospital."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikki","family":"Burish","sequence":"additional","affiliation":[{"name":"From the Division of Plastic and Reconstructive Surgery, Department of Surgery, Mount Sinai Hospital."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Taub","sequence":"additional","affiliation":[{"name":"From the Division of Plastic and Reconstructive Surgery, Department of Surgery, Mount Sinai Hospital."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20231015","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1098\/rstb.1999.0377","article-title":"Tetanus and botulinum neurotoxins: Mechanism of action and therapeutic uses.","volume":"354","author":"Pellizzari","year":"1999","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"R2-20231015","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/ane.12906","article-title":"Botulinum toxin: A review of the mode of action in migraine.","volume":"137","author":"Do","year":"2018","journal-title":"Acta Neurol Scand"},{"key":"R3-20231015","first-page":"1","article-title":"Genetic diversity within Clostridium botulinum serotypes, botulinum neurotoxin gene clusters and toxin subtypes.","volume":"364","author":"Hill","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"R4-20231015","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.febslet.2010.11.045","article-title":"Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1.","volume":"585","author":"Pier","year":"2011","journal-title":"FEBS Lett"},{"key":"R5-20231015","doi-asserted-by":"crossref","first-page":"e00795-16","DOI":"10.1128\/IAI.00795-16","article-title":"Entry of botulinum neurotoxin subtypes A1 and A2 into neurons.","volume":"85","author":"Kroken","year":"2017","journal-title":"Infect Immun"},{"key":"R6-20231015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.toxicon.2010.10.009","article-title":"Comparison of effects of botulinum toxin subtype A1 and A2 using twitch tension assay and rat grip strength test.","volume":"57","author":"Torii","year":"2011","journal-title":"Toxicon"},{"key":"R7-20231015","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.toxicon.2013.11.006","article-title":"Comparison of the immunogenicity of botulinum toxin type A and the efficacy of A1 and A2 neurotoxins in animals with A1 toxin antibodies.","volume":"77","author":"Torii","year":"2014","journal-title":"Toxicon"},{"key":"R8-20231015","first-page":"3233","article-title":"Botulinum neurotoxin D-C uses synaptotagmin I and II as receptors, and human synaptotagmin II is not an effective receptor for type B, D-C and G toxins.","volume":"125","author":"Peng","year":"2012","journal-title":"J Cell Sci"},{"key":"R9-20231015","first-page":"227","article-title":"Botulinum toxin type A products are not interchangeable: A review of the evidence.","volume":"8","author":"Brin","year":"2014","journal-title":"Biologics"},{"key":"R10-20231015","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3390\/toxins4100913","article-title":"Clinical uses of botulinum neurotoxins: Current indications, limitations and future developments.","volume":"4","author":"Chen","year":"2012","journal-title":"Toxins (Basel)"},{"key":"R12-20231015","doi-asserted-by":"crossref","first-page":"519e","DOI":"10.1097\/PRS.0000000000002480","article-title":"Current uses of botulinum neurotoxins in plastic surgery.","volume":"138","author":"Noland","year":"2016","journal-title":"Plast Reconstr Surg"},{"issue":"Suppl","key":"R13-20231015","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1097\/01.PRS.0000082188.55598.34","article-title":"Botulinum toxin: Expanding role in medicine.","volume":"112","author":"Rohrich","year":"2003","journal-title":"Plast Reconstr Surg"},{"issue":"Suppl","key":"R14-20231015","doi-asserted-by":"crossref","first-page":"177S","DOI":"10.1097\/01.PRS.0000082208.37239.5B","article-title":"The cosmetic use of botulinum toxin.","volume":"112","author":"Rohrich","year":"2003","journal-title":"Plast Reconstr Surg"},{"key":"R15-20231015","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/0333102413485658","article-title":"The International Classification of Headache Disorders, 3rd edition (beta version).","volume":"33","year":"2013","journal-title":"Cephalalgia"},{"key":"R16-20231015","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/B978-0-444-62627-1.00025-1","article-title":"Headache and migraine: A leading cause of absenteeism.","volume":"131","author":"Baigi","year":"2015","journal-title":"Handb Clin Neurol"},{"issue":"Suppl 2","key":"R17-20231015","doi-asserted-by":"crossref","first-page":"131S","DOI":"10.1097\/PRS.0000000000000661","article-title":"A review of current evidence in the surgical treatment of migraine headaches.","volume":"134","author":"Janis","year":"2014","journal-title":"Plast Reconstr Surg"},{"key":"R18-20231015","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s40265-018-0894-6","article-title":"OnabotulinumtoxinA: A review in the prevention of chronic migraine.","volume":"78","author":"Frampton","year":"2018","journal-title":"Drugs"},{"key":"R19-20231015","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1526-4610.2011.01990.x","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: Pooled analyses of the 56-week PREEMPT clinical program.","volume":"51","author":"Aurora","year":"2011","journal-title":"Headache"},{"key":"R20-20231015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s10194-018-0840-8","article-title":"Long-term study of the efficacy and safety of onabotulinumtoxinA for the prevention of chronic migraine: COMPEL study.","volume":"19","author":"Blumenfeld","year":"2018","journal-title":"J Headache Pain"},{"key":"R21-20231015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s10194-017-0802-6","article-title":"Real-life use of onabotulinumtoxinA for symptom relief in patients with chronic migraine: REPOSE study methodology and baseline data.","volume":"18","author":"Davies","year":"2017","journal-title":"J Headache Pain"},{"key":"R22-20231015","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1212\/WNL.0000000000002560","article-title":"Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache. Report of the Guideline Development Subcommittee of the American Academy of Neurology.","volume":"86","author":"Simpson","year":"2016","journal-title":"Neurology"},{"issue":"Suppl 1","key":"R23-20231015","first-page":"I12","article-title":"Botulinum toxin in tension-type headache.","volume":"251","author":"Relja","year":"2004","journal-title":"J Neurol"},{"key":"R24-20231015","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1468-2982.2004.00738.x","article-title":"Treatment of chronic tension-type headache with botulinum toxin: A double-blind, placebo-controlled clinical trial.","volume":"24","author":"Padberg","year":"2004","journal-title":"Cephalalgia"},{"key":"R25-20231015","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1177\/0333102410364677","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial.","volume":"30","author":"Diener","year":"2010","journal-title":"Cephalalgia"},{"key":"R26-20231015","doi-asserted-by":"crossref","first-page":"e1270","DOI":"10.1097\/GOX.0000000000001270","article-title":"Targeted peripheral nerve-directed onabotulinumtoxin A injection for effective long-term therapy for migraine headache.","volume":"5","author":"Janis","year":"2017","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"Suppl","key":"R27-20231015","doi-asserted-by":"crossref","first-page":"104S","DOI":"10.1097\/PRS.0000000000001732","article-title":"Neurotoxins: Expanding uses of neuromodulators in medicine\u2014Headache.","volume":"136","author":"Nahabet","year":"2015","journal-title":"Plast Reconstr Surg"},{"key":"R28-20231015","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/art.34453","article-title":"Osteoarthritis: A disease of the joint as an organ.","volume":"64","author":"Loeser","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R29-20231015","doi-asserted-by":"crossref","first-page":"16072","DOI":"10.1038\/nrdp.2016.72","article-title":"Osteoarthritis.","volume":"2","author":"Martel-Pelletier","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"R30-20231015","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jbspin.2015.10.001","article-title":"Usefulness of intra-articular botulinum toxin injections: A systematic review.","volume":"83","author":"Khenioui","year":"2016","journal-title":"Joint Bone Spine"},{"key":"R31-20231015","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/AJP.0000000000000538","article-title":"Efficacy of intra-articular botulinum toxin in osteoarticular joint pain: A meta-analysis of randomized controlled trials.","volume":"34","author":"Courseau","year":"2018","journal-title":"Clin J Pain"},{"key":"R32-20231015","first-page":"e2","article-title":"Aetiology and pathogenesis of trigeminal neuralgia: A comprehensive review.","volume":"3","author":"Sabalys","year":"2013","journal-title":"J Oral Maxillofac Res"},{"key":"R33-20231015","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/00002826-200209000-00006","article-title":"Beneficial effects of botulinum toxin type a for patients with painful tic convulsif.","volume":"25","author":"Micheli","year":"2002","journal-title":"Clin Neuropharmacol"},{"key":"R34-20231015","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/0333102412441721","article-title":"Botulinum toxin type A for the treatment of trigeminal neuralgia: Results from a randomized, double-blind, placebo-controlled trial.","volume":"32","author":"Wu","year":"2012","journal-title":"Cephalalgia"},{"key":"R35-20231015","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s10194-017-0793-3","article-title":"Single-dose botulinum toxin type a compared with repeated-dose for treatment of trigeminal neuralgia: A pilot study.","volume":"18","author":"Zhang","year":"2017","journal-title":"J Headache Pain"},{"key":"R36-20231015","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/AJP.0000000000000577","article-title":"Efficacy of 8 different drug treatments for patients with trigeminal neuralgia: A network meta-analysis.","volume":"34","author":"Yang","year":"2018","journal-title":"Clin J Pain"},{"key":"R37-20231015","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s40261-017-0553-9","article-title":"Interventions for refractory trigeminal neuralgia: A Bayesian mixed treatment comparison network meta-analysis of randomized controlled clinical trials.","volume":"37","author":"Sridharan","year":"2017","journal-title":"Clin Drug Investig"},{"key":"R38-20231015","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMcp1403062","article-title":"Clinical practice: Postherpetic neuralgia.","volume":"371","author":"Johnson","year":"2014","journal-title":"N Engl J Med"},{"key":"R39-20231015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1526-4637.2006.00100.x","article-title":"Botulinum toxin A relieved neuropathic pain in a case of post-herpetic neuralgia.","volume":"7","author":"Liu","year":"2006","journal-title":"Pain Med"},{"key":"R40-20231015","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.oooo.2016.03.003","article-title":"The efficacy of botulinum toxin for the treatment of trigeminal and postherpetic neuralgia: A systematic review with meta-analyses.","volume":"122","author":"Shackleton","year":"2016","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"R41-20231015","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2340\/00015555-0609","article-title":"Severe post-herpetic neuralgia successfully treated with botulinum toxin A: Three case reports.","volume":"89","author":"Sotiriou","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"R42-20231015","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1111\/j.1526-4637.2010.01003.x","article-title":"Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia.","volume":"11","author":"Xiao","year":"2010","journal-title":"Pain Med"},{"issue":"Suppl","key":"R43-20231015","doi-asserted-by":"crossref","first-page":"T12","DOI":"10.1016\/j.jpain.2011.08.001","article-title":"Study methods, recruitment, sociodemographic findings, and demographic representativeness in the OPPERA study.","volume":"12","author":"Slade","year":"2011","journal-title":"J Pain"},{"key":"R44-20231015","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.joms.2017.01.031","article-title":"Effectiveness, safety, and predictors of response to botulinum toxin type A in refractory masticatory myalgia: A retrospective study.","volume":"75","author":"Khawaja","year":"2017","journal-title":"J Oral Maxillofac Surg"},{"key":"R45-20231015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40902-016-0051-7","article-title":"A clinical evaluation of botulinum toxin-A injections in the temporomandibular disorder treatment.","volume":"38","author":"Kim","year":"2016","journal-title":"Maxillofac Plast Reconstr Surg"},{"key":"R46-20231015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.adaj.2016.09.013","article-title":"Effectiveness of botulinum toxin type A for the treatment of chronic masticatory myofascial pain: A case series.","volume":"148","author":"Baker","year":"2017","journal-title":"J Am Dent Assoc"},{"key":"R47-20231015","first-page":"122","article-title":"Effect of injection of botulinum toxin on lateral pterygoid muscle used together with the arthroscopy in patients with anterior disk displacement of the temporomandibular joint.","volume":"19","author":"Arinci","year":"2009","journal-title":"Kulak Burun Bogaz Ihtis Derg"},{"key":"R48-20231015","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/04.SCS.0000157263.73768.64","article-title":"Botulinum toxin for the treatment of temporomandibular joint disk disfigurement: Clinical experience.","volume":"16","author":"Karacalar","year":"2005","journal-title":"J Craniofac Surg"},{"key":"R49-20231015","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.ijom.2015.04.003","article-title":"Botulinum toxin therapy for temporomandibular joint disorders: A systematic review of randomized controlled trials.","volume":"44","author":"Chen","year":"2015","journal-title":"Int J Oral Maxillofac Surg"},{"key":"R50-20231015","first-page":"CD003633","article-title":"Botulinum toxin type A therapy for cervical dystonia.","volume":"12","author":"Castel\u00e3o","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R51-20231015","first-page":"CD004315","article-title":"Botulinum toxin type B for cervical dystonia.","volume":"5","author":"Marques","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"Movement Disorders","key":"R52-20231015","first-page":"131","article-title":"Neurotoxin injection for movement disorders.","volume":"16","author":"Charles","year":"2010","journal-title":"Continuum (Minneap Minn.)"},{"key":"R54-20231015","first-page":"CD004314","article-title":"Botulinum toxin type A versus botulinum toxin type B for cervical dystonia.","volume":"1","author":"Costa","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"R55-20231015","first-page":"CD004899","article-title":"Botulinum toxin type A therapy for hemifacial spasm.","volume":"1","author":"Costa","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"R56-20231015","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10143-010-0254-9","article-title":"Microvascular decompression for treating hemifacial spasm: Lessons learned from a prospective study of 1,174 operations.","volume":"33","author":"Hyun","year":"2010","journal-title":"Neurosurg Rev"},{"key":"R57-20231015","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0025-6196(12)64977-5","article-title":"Treatment of blepharospasm with botulinum toxin.","volume":"64","author":"Kennedy","year":"1989","journal-title":"Mayo Clin Proc"},{"key":"R58-20231015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ana.410110108","article-title":"Treatment of hyperkinetic movement disorders with tetrabenazine: A double-blind crossover study.","volume":"11","author":"Jankovic","year":"1982","journal-title":"Ann Neurol"},{"key":"R59-20231015","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1212\/01.wnl.0000311389.26145.95","article-title":"Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review). Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.","volume":"70","author":"Simpson","year":"2008","journal-title":"Neurology"},{"key":"R60-20231015","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.toxicon.2012.12.004","article-title":"Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders.","volume":"67","author":"Hallett","year":"2013","journal-title":"Toxicon"},{"key":"R62-20231015","first-page":"CD007510","article-title":"Botulinum toxin for masseter hypertrophy.","volume":"9","author":"Fedorowicz","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R63-20231015","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/archfaci.6.3.188","article-title":"Botulinum toxin for masseter reduction in Asian patients.","volume":"6","author":"Ahn","year":"2004","journal-title":"Arch Facial Plast Surg"},{"key":"R64-20231015","doi-asserted-by":"crossref","first-page":"39e","DOI":"10.1097\/PRS.0000000000005083","article-title":"The masseter muscle and its role in facial contouring, aging, and quality of life: A literature review.","volume":"143","author":"Almukhtar","year":"2019","journal-title":"Plast Reconstr Surg"},{"key":"R65-20231015","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1111\/dsu.12317","article-title":"Consensus recommendations on the aesthetic usage of botulinum toxin type A in Asians.","volume":"39","author":"Ahn","year":"2013","journal-title":"Dermatol Surg"},{"key":"R66-20231015","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1097\/PRS.0b013e3181d0ad03","article-title":"Botulinum toxin type A for the treatment of hypertrophy of the masseter muscle.","volume":"125","author":"Kim","year":"2010","journal-title":"Plast Reconstr Surg"},{"key":"R67-20231015","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/01.PRS.0000153236.79775.A0","article-title":"The use of botulinum toxin type A in aesthetic mandibular contouring.","volume":"115","author":"Kim","year":"2005","journal-title":"Plast Reconstr Surg"},{"key":"R68-20231015","doi-asserted-by":"crossref","first-page":"209e","DOI":"10.1097\/PRS.0000000000000371","article-title":"Classification of masseter hypertrophy for tailored botulinum toxin type A treatment.","volume":"134","author":"Xie","year":"2014","journal-title":"Plast Reconstr Surg"},{"key":"R69-20231015","doi-asserted-by":"crossref","first-page":"e559","DOI":"10.1212\/WNL.0000000000004951","article-title":"Onabotulinum toxin-A injections for sleep bruxism: A double-blind, placebo-controlled study.","volume":"90","author":"Ondo","year":"2018","journal-title":"Neurology"},{"key":"R70-20231015","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/00129492-200411000-00026","article-title":"Expression of emotion and quality of life after facial nerve paralysis.","volume":"25","author":"Coulson","year":"2004","journal-title":"Otol Neurotol"},{"key":"R71-20231015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/000164802760370736","article-title":"Bell\u2019s palsy: The spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies.","volume":"549","author":"Peitersen","year":"2002","journal-title":"Acta Otolaryngol Suppl"},{"key":"R72-20231015","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1288\/00005537-197911000-00020","article-title":"Mechanisms of synkinesis.","volume":"89","author":"Crumley","year":"1979","journal-title":"Laryngoscope"},{"key":"R73-20231015","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00006534-198908000-00027","article-title":"Botulinum toxin: A treatment for facial asymmetry caused by facial nerve paralysis.","volume":"84","author":"Clark","year":"1989","journal-title":"Plast Reconstr Surg"},{"key":"R74-20231015","first-page":"295","article-title":"Botulinum toxin treatment of synkinesia following facial paralysis (in German).","volume":"38","author":"Roggenk\u00e4mper","year":"1990","journal-title":"HNO"},{"key":"R75-20231015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.fsc.2015.09.008","article-title":"Botulinum toxin in the treatment of facial paralysis.","volume":"24","author":"Mehdizadeh","year":"2016","journal-title":"Facial Plast Surg Clin North Am"},{"key":"R76-20231015","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/01676830490512233","article-title":"Treatment of aberrant facial nerve regeneration with botulinum toxin A.","volume":"23","author":"Chua","year":"2004","journal-title":"Orbit"},{"key":"R77-20231015","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1600-0404.2006.00746.x","article-title":"Low-dose subcutaneous injection of botulinum toxin type A for facial synkinesis and hyperlacrimation.","volume":"115","author":"Ito","year":"2007","journal-title":"Acta Neurol Scand"},{"key":"R78-20231015","doi-asserted-by":"crossref","first-page":"882","DOI":"10.3109\/00016489.2011.577447","article-title":"Combined protocol for treatment of secondary effects from facial nerve palsy.","volume":"131","author":"Monini","year":"2011","journal-title":"Acta Otolaryngol"},{"key":"R79-20231015","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/01.PRS.0000169689.27829.C4","article-title":"Botulinum toxin for aberrant facial nerve regeneration: Double-blind, placebo-controlled trial using subjective endpoints.","volume":"116","author":"Borodic","year":"2005","journal-title":"Plast Reconstr Surg"},{"key":"R80-20231015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/PRS.0000000000000800","article-title":"Comparison of the efficacy of onabotulinumtoxinA and abobotulinumtoxinA at the 1:3 conversion ratio for the treatment of asymmetry after long-term facial paralysis.","volume":"135","author":"do Nascimento Remigio","year":"2015","journal-title":"Plast Reconstr Surg"},{"key":"R81-20231015","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MAO.0b013e31827c9f58","article-title":"Contralateral botulinum toxin injection to improve facial asymmetry after acute facial paralysis.","volume":"34","author":"Kim","year":"2013","journal-title":"Otol Neurotol"},{"key":"R82-20231015","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/0194599811424125","article-title":"Mirror biofeedback rehabilitation after administration of single-dose botulinum toxin for treatment of facial synkinesis.","volume":"146","author":"Azuma","year":"2012","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R83-20231015","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.bjps.2017.01.009","article-title":"Botulinum toxin treatment for facial palsy: A systematic review.","volume":"70","author":"Cooper","year":"2017","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R84-20231015","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1749-4486.2006.01263.x","article-title":"Botulinum toxin in the management of sialorrhoea: A systematic review.","volume":"31","author":"Lim","year":"2006","journal-title":"Clin Otolaryngol"},{"key":"R85-20231015","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/mds.23473","article-title":"Botulinum toxin A versus B in sialorrhea: A prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson\u2019s disease.","volume":"26","author":"Guidubaldi","year":"2011","journal-title":"Mov Disord"},{"key":"R86-20231015","first-page":"CD006981","article-title":"Treatment for sialorrhea (excessive saliva) in people with motor neuron disease\/amyotrophic lateral sclerosis.","volume":"5","author":"Young","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"R87-20231015","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/0194599812465059","article-title":"Botulinum toxin for the treatment of sialorrhea: A meta-analysis.","volume":"148","author":"Vashishta","year":"2013","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R88-20231015","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00415-009-0085-1","article-title":"Long-lasting benefits of botulinum toxin type B in Parkinson\u2019s disease-related drooling.","volume":"256","author":"Lagalla","year":"2009","journal-title":"J Neurol"},{"key":"R89-20231015","doi-asserted-by":"crossref","first-page":"E217","DOI":"10.3390\/toxins10060217","article-title":"Incobotulinumtoxin A for sialorrhea in neurological disorders: A real-life experience.","volume":"10","author":"Martinez-Poles","year":"2018","journal-title":"Toxins (Basel)"},{"key":"R90-20231015","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.3390\/toxins5051010","article-title":"Sialorrhea: Anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins.","volume":"5","author":"Lakraj","year":"2013","journal-title":"Toxins (Basel)"},{"key":"R91-20231015","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2133.2004.06334.x","article-title":"Psychosocial aspects of patients with focal hyperhidrosis: Marked reduction of social phobia, anxiety and depression and increased quality of life after treatment with botulinum toxin A.","volume":"152","author":"Weber","year":"2005","journal-title":"Br J Dermatol"},{"key":"R92-20231015","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0190-9622(89)70081-5","article-title":"Biology of sweat glands and their disorders: II. Disorders of sweat gland function.","volume":"20","author":"Sato","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"R93-20231015","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1365-2133.1999.02769.x","article-title":"A randomized, double-blind, placebo-controlled trial of botulinum A toxin for severe axillary hyperhidrosis.","volume":"140","author":"Schnider","year":"1999","journal-title":"Br J Dermatol"},{"key":"R94-20231015","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/bmj.323.7313.596","article-title":"Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: Randomised, parallel group, double blind, placebo controlled trial.","volume":"323","author":"Naumann","year":"2001","journal-title":"BMJ"},{"key":"R95-20231015","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1365-2133.2007.07760.x","article-title":"Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: A randomized, side-by-side, double-blind study.","volume":"156","author":"Vadoud-Seyedi","year":"2007","journal-title":"Br J Dermatol"},{"key":"R96-20231015","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.det.2014.06.012","article-title":"Botulinum neurotoxin treatment of palmar and plantar hyperhidrosis.","volume":"32","author":"Weinberg","year":"2014","journal-title":"Dermatol Clin"},{"key":"R97-20231015","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/pde.13628","article-title":"Sweaty feet in adolescents: Early use of botulinum type A toxin in juvenile plantar hyperhidrosis.","volume":"35","author":"Bernhard","year":"2018","journal-title":"Pediatr Dermatol"},{"key":"R98-20231015","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1046\/j.1365-2133.1997.d01-1233.x","article-title":"Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms.","volume":"136","author":"Schnider","year":"1997","journal-title":"Br J Dermatol"},{"key":"R99-20231015","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/1090820X11434506","article-title":"Treatment of hyperhidrosis with botulinum toxin.","volume":"32","author":"Doft","year":"2012","journal-title":"Aesthet Surg J"},{"key":"R100-20231015","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/cam4.504","article-title":"Efficacy and safety of botulinum toxin type A for treatment of Frey\u2019s syndrome: Evidence from 22 published articles.","volume":"4","author":"Xie","year":"2015","journal-title":"Cancer Med"},{"key":"R101-20231015","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1590\/abd1806-4841.20175702","article-title":"Use of botulinum toxin type A in Frey\u2019s syndrome.","volume":"92","author":"Gualberto","year":"2017","journal-title":"An Bras Dermatol"},{"key":"R102-20231015","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/hed.10262","article-title":"Treatment of gustatory sweating (Frey\u2019s syndrome) with botulinum toxin A.","volume":"25","author":"Eckardt","year":"2003","journal-title":"Head Neck"},{"key":"R103-20231015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bjps.2012.09.012","article-title":"Use of botulinum toxin type A to improve treatment of facial wounds: A prospective randomised study.","volume":"66","author":"Ziade","year":"2013","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R104-20231015","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1177\/229255031502300402","article-title":"Botulinum toxin for the prevention and healing of wound scars: A systematic review of the literature.","volume":"23","author":"Prodromidou","year":"2015","journal-title":"Plast Surg (Oakv.)"},{"key":"R105-20231015","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/PRS.0000000000004110","article-title":"Effects of botulinum toxin on improving facial surgical scars: A prospective, split-scar, double-blind, randomized controlled trial.","volume":"141","author":"Hu","year":"2018","journal-title":"Plast Reconstr Surg"},{"key":"R106-20231015","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.4065\/81.8.1023","article-title":"Botulinum toxin to improve facial wound healing: A prospective, blinded, placebo-controlled study.","volume":"81","author":"Gassner","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"R107-20231015","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/wrr.12204","article-title":"Early postoperative treatment of thyroidectomy scars using botulinum toxin: A split-scar, double-blind randomized controlled trial.","volume":"22","author":"Kim","year":"2014","journal-title":"Wound Repair Regen"},{"key":"R108-20231015","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJMra1507638","article-title":"Raynaud\u2019s phenomenon.","volume":"375","author":"Wigley","year":"2016","journal-title":"N Engl J Med"},{"key":"R109-20231015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.hcl.2013.09.006","article-title":"Minimally invasive treatment of Raynaud phenomenon: The role of botulinum type A.","volume":"30","author":"Neumeister","year":"2014","journal-title":"Hand Clin"},{"key":"R110-20231015","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jhsa.2012.01.021","article-title":"The effect of botulinum neurotoxin-A on blood flow in rats: A potential mechanism for treatment of Raynaud phenomenon.","volume":"37","author":"Stone","year":"2012","journal-title":"J Hand Surg Am"},{"key":"R111-20231015","doi-asserted-by":"crossref","first-page":"864","DOI":"10.5114\/aoms.2015.48152","article-title":"Botulinum toxin A in the treatment of Raynaud\u2019s phenomenon: A systematic review.","volume":"12","author":"\u017bebryk","year":"2016","journal-title":"Arch Med Sci"},{"key":"R114-20231015","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jpedsurg.2005.12.023","article-title":"Effect of paralysis of the abdominal wall muscles by botulinum A toxin to intraabdominal pressure: An experimental study.","volume":"41","author":"Cakmak","year":"2006","journal-title":"J Pediatr Surg"},{"key":"R115-20231015","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1007\/s00464-018-6089-0","article-title":"Preoperative combination of progressive pneumoperitoneum and botulinum toxin type A in patients with loss of domain hernia.","volume":"32","author":"Bueno-Lled\u00f3","year":"2018","journal-title":"Surg Endosc"},{"key":"R116-20231015","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/ans.13258","article-title":"Preoperative abdominal muscle elongation with botulinum toxin A for complex incisional ventral hernia repair.","volume":"86","author":"Farooque","year":"2016","journal-title":"ANZ J Surg"},{"key":"R117-20231015","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1007\/s00268-009-0203-3","article-title":"Use of botulinum toxin type a before abdominal wall hernia reconstruction.","volume":"33","author":"Ibarra-Hurtado","year":"2009","journal-title":"World J Surg"},{"key":"R118-20231015","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10029-014-1280-2","article-title":"Effect of botulinum toxin type A in lateral abdominal wall muscles thickness and length of patients with midline incisional hernia secondary to open abdomen management.","volume":"18","author":"Ibarra-Hurtado","year":"2014","journal-title":"Hernia"},{"key":"R119-20231015","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00464-017-5750-3","article-title":"Preoperative botulinum toxin A enabling defect closure and laparoscopic repair of complex ventral hernia.","volume":"32","author":"Rodriguez-Acevedo","year":"2018","journal-title":"Surg Endosc"},{"key":"R120-20231015","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1526-4637.2011.01147.x","article-title":"Botox A injection for pain after laparoscopic ventral hernia: A case report.","volume":"12","author":"Smoot","year":"2011","journal-title":"Pain Med"},{"key":"R121-20231015","doi-asserted-by":"crossref","first-page":"e1358","DOI":"10.1097\/GOX.0000000000001358","article-title":"Botulinum toxin A as an adjunct to abdominal wall reconstruction for incisional hernia.","volume":"5","author":"Soltanizadeh","year":"2017","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"R122-20231015","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1007\/s00268-013-2211-6","article-title":"Outcomes of chemical component paralysis using botulinum toxin for incisional hernia repairs.","volume":"37","author":"Zendejas","year":"2013","journal-title":"World J Surg"},{"key":"R123-20231015","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10029-012-0995-1","article-title":"Chemical components separation with botulinum toxin A: A novel technique to improve primary fascial closure rates of the open abdomen.","volume":"17","author":"Zielinski","year":"2013","journal-title":"Hernia"},{"key":"R124-20231015","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00464-016-5030-7","article-title":"Preoperative chemical component relaxation using botulinum toxin A: Enabling laparoscopic repair of complex ventral hernia.","volume":"31","author":"Elstner","year":"2017","journal-title":"Surg Endosc"},{"key":"R125-20231015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10029-013-1168-6","article-title":"Criteria for definition of a complex abdominal wall hernia.","volume":"18","author":"Slater","year":"2014","journal-title":"Hernia"},{"key":"R126-20231015","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10029-017-1582-2","article-title":"Preoperative progressive pneumoperitoneum and botulinum toxin type A in patients with large incisional hernia.","volume":"21","author":"Bueno-Lled\u00f3","year":"2017","journal-title":"Hernia"},{"issue":"Suppl","key":"R127-20231015","doi-asserted-by":"crossref","first-page":"58S","DOI":"10.1097\/PRS.0000000000004856","article-title":"Chemical components separation: Concepts, evidence, and outcomes.","volume":"142","author":"Motz","year":"2018","journal-title":"Plast Reconstr Surg"},{"key":"R128-20231015","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/01.sla.0000141156.56314.1f","article-title":"Botulinum toxin infiltration for pain control after mastectomy and expander reconstruction.","volume":"240","author":"Layeeque","year":"2004","journal-title":"Ann Surg"},{"key":"R129-20231015","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/asj\/sjv040","article-title":"The efficacy of botulinum toxin A in post-mastectomy breast reconstruction: A pilot study.","volume":"35","author":"Gabriel","year":"2015","journal-title":"Aesthet Surg J"},{"key":"R130-20231015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/SAP.0b013e31829be8d8","article-title":"A blinded randomized controlled trial to evaluate the use of botulinum toxin for pain control in breast reconstruction with tissue expanders.","volume":"74","author":"Lo","year":"2015","journal-title":"Ann Plast Surg"},{"key":"R131-20231015","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bjps.2013.09.012","article-title":"A systematic review of the use of botulinum toxin type A with subpectoral breast implants.","volume":"67","author":"Winocour","year":"2014","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R132-20231015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/SAP.0000000000000005","article-title":"The effect of Botox on the implant stabilization and capsular formation: An experimental study.","volume":"75","author":"Irkoren","year":"2015","journal-title":"Ann Plast Surg"},{"key":"R133-20231015","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/iwj.12228","article-title":"The effect of botulinum neurotoxin type A on capsule formation around silicone implants: The in vivo and in vitro study.","volume":"13","author":"Lee","year":"2016","journal-title":"Int Wound J"},{"key":"R134-20231015","doi-asserted-by":"crossref","first-page":"821e","DOI":"10.1097\/PRS.0000000000002625","article-title":"Effect of botulinum toxin type A on TGF-\u03b2\/Smad pathway signaling: Implications for silicone-induced capsule formation.","volume":"138","author":"Kim","year":"2016","journal-title":"Plast Reconstr Surg"},{"key":"R135-20231015","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s00266-009-9319-y","article-title":"Effect of botulinum toxin type A on the capsule around a subpectoral implant for breast augmentation.","volume":"33","author":"Xiao","year":"2009","journal-title":"Aesthetic Plast Surg"},{"key":"R136-20231015","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00266-018-1203-1","article-title":"Botulinum toxin A plays an important role in the placement of implants deep within the pectoralis major muscle for mammaplasty: A systematic review and meta-analysis.","volume":"42","author":"Li","year":"2018","journal-title":"Aesthetic Plast Surg"}],"container-title":["Plastic &amp; Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PRS.0000000000006908","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T04:16:33Z","timestamp":1697343393000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PRS.0000000000006908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":131,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/prs.0000000000006908","relation":{},"ISSN":["0032-1052"],"issn-type":[{"value":"0032-1052","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]}}}